uniQure (QURE) EBT Margin Growth (5y) (2021 - 2026)
Powered by 
Analysis
uniQure (QURE) EBT Margin Growth (5y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -144,306.00 |
| Mar 31, 2026 | 761,714.00 |
| Dec 31, 2025 | -68,617.00 |
| Sep 30, 2025 | 106,307.00 |
| Jun 30, 2025 | 206,331.00 |
| Mar 31, 2025 | 2.42 Mn |
| Dec 31, 2024 | 19,133.00 |
| Sep 30, 2024 | 31,480.00 |
| Jun 30, 2024 | 77,167.00 |
| Mar 31, 2024 | 167,911.00 |
| Dec 31, 2023 | 47,718.00 |
| Sep 30, 2023 | -567,002.00 |
| Jun 30, 2023 | -215,713.00 |
| Mar 31, 2023 | -93,007.00 |
| Dec 31, 2022 | 106,660.00 |
| Sep 30, 2022 | -285,985.00 |
| Jun 30, 2022 | -749,297.00 |
| Mar 31, 2022 | -202,876.00 |
| Dec 31, 2021 | 16,673.00 |
| Sep 30, 2021 | -162,313.00 |